Fibrin
Modify Date: 2024-01-04 02:42:38
Fibrin structure
|
Common Name | Fibrin | ||
|---|---|---|---|---|
| CAS Number | 9001-31-4 | Molecular Weight | 145.16000 | |
| Density | 1.146g/cm3 | Boiling Point | 471.7ºC at 760mmHg | |
| Molecular Formula | C5H11N3O2 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | 239.1ºC | |
Use of FibrinFibrin, isolated from bovine blood, is an insoluble protein produced in response to bleeding. Fibrin is the major component of the blood clot and is used for coagulation[1]. |
| Name | 2-amino-N-[2-(methylamino)-2-oxoethyl]acetamide |
|---|---|
| Synonym | More Synonyms |
| Description | Fibrin, isolated from bovine blood, is an insoluble protein produced in response to bleeding. Fibrin is the major component of the blood clot and is used for coagulation[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.146g/cm3 |
|---|---|
| Boiling Point | 471.7ºC at 760mmHg |
| Molecular Formula | C5H11N3O2 |
| Molecular Weight | 145.16000 |
| Flash Point | 239.1ºC |
| Exact Mass | 145.08500 |
| PSA | 91.20000 |
| LogP | 0.18820 |
| Index of Refraction | 1.48 |
| Storage condition | 2-8°C |
| Safety Phrases | 22-24/25 |
|---|---|
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
|
Thrombin inhibition with dabigatran protects against high-fat diet-induced fatty liver disease in mice.
J. Pharmacol. Exp. Ther. 351(2) , 288-97, (2014) Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of obesity and metabolic syndrome. Robust coagulation cascade activation is common in obese patients with NAFLD. We identified a c... |
|
|
Novel thrombolytic protease from edible and medicinal plant Aster yomena (Kitam.) Honda with anticoagulant activity: purification and partial characterization.
J. Biosci. Bioeng. 118(4) , 372-7, (2014) A thrombolytic protease named kitamase possessing anticoagulant property was purified from edible and medicinal plant Aster yomena (Kitam.) Honda. Kitamase showed a molecular weight of 50 kDa by SDS-P... |
|
|
The effect of etanercept on lung leukocyte margination and fibrin deposition after cardiac surgery.
Am. J. Respir. Crit. Care Med. 188(6) , 751-4, (2013)
|
| 2-[(2-Aminoacetyl)amino]-N-methylacetamide |
| FIBRIN,TECH |
| 2-amino-N-[(methylcarbamoyl)methyl]acetamide |
| MFCD00131058 |
| EINECS 232-597-0 |
| FIBRIN |